Online citations, reference lists, and bibliographies.
← Back to Search

Pharmacological Evaluation Of An Injectable Prolonged Release Emulsion Of Physostigmine In Rabbits

S. Benita, D. Friedman, M. Weinstock
Published 1986 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Physostigmine was incorporated in an injectable emulsion in an attempt to prolong its pharmacological activity. Emulsions which remained stable over 6 month storage were prepared using optimal experimental conditions. The in‐vitro kinetic examination revealed that the rate‐determining step in the release process of physostigmine from the emulsion was its partitioning from the oily phase to the external aqueous phase. The in‐vivo results indicated that the physostigmine emulsion was able to inhibit the cholinesterase activity for at least 4 h, while the conventional injection inhibited the cholinesterase activity for only 1 to 2 h. The preliminary pharmacokinetic analysis showed that the physostigmine emulsion apparently increased the bioavailability compared with the conventional injectable solution. This could be attributed either to the protection of the sensitive drug from the enzymatic degradation or to improved absorption. The presence of poloxamer micelles in the aqueous phase was shown to enhance the bioavailability of physostigmine without having any effect on its pharmacological activity or duration.



This paper is referenced by
10.1016/0166-6622(91)80014-F
Penetration of poly(oxyethylene)—poly (oxypropylene) block copolymer surfactant into soya phospholipid monolayers
N. Magalhaes (1991)
10.1016/0378-5173(90)90140-Y
Enhanced stability of physostigmine salicylate in submicron o/w emulsion
Yashwant V. Pathak (1990)
Development and Evaluation of Nanoemulsion of Repaglinide
Basavaraj K. Nanjwade (2014)
10.1016/0378-5173(90)90280-H
Drug release from microdisperse systems: a critical review
C. Washington (1990)
10.1007/s13346-012-0088-9
Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research
D. Mishra (2012)
10.1016/S1461-5347(99)00141-8
Top ten considerations in the development of parenteral emulsions.
Floyd (1999)
10.1002/JPS.2600821102
Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization.
S. Benita (1993)
10.3109/10837459809028627
Prolonged release of drug from O/w emulsion and residence in rat nasal cavity.
K. Aikawa (1998)
10.7282/T3765D5F
Development and characterization of lipid based nanosystems of quercetin for topical delivery
Sonali Bose (2012)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1046/j.1365-2710.1998.00139.x
Naproxen incorporated lipid emulsions. I. Formulation and stability studies
S. Nasirideen (1998)
10.1016/S0169-409X(96)00467-X
Emulsion formulations as a vector for gene delivery in vitro and in vivo
T. Hara (1997)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1201/9780849350610.CH4
In Vitro/In Vivo Release from Injectable Dispersed Systems
I. Pyrah (2005)
10.1007/S11746-997-0053-9
Microfiltration and stabilization of egg yolk phospholipid emulsions by a microporous glass membrane
Y. Mine (1997)
10.1016/S0939-6411(97)00170-7
Mixture experiments with the oil phase of parenteral emulsions.
M. Jumaa (1998)
10.1016/S0378-5173(97)00186-5
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system
O. El-Gazayerly (1997)
10.3109/03639048709068707
A Mathematical Morel for Drug Release from 0/W Emulsions: Application to Controlled Release Morphine Emulsions
D. Friedman (1987)
10.1081/DDC-100102220
Interaction of soybean oil with phosphatidylcholine and their formation of small dispersed particles.
Y. Asai (1999)
10.1016/J.JDDST.2015.11.004
Levofloxacin hemihydrate ocular semi-sponges for topical treatment of bacterial conjunctivitis: Formulation and in-vitro/in-vivo characterization
Osama Saher (2016)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1002/JCCS.198800070
Encapsulation and Prolonged Release Behaviour of W/O/W Type Multiple Emulsions
Tsui-Hua Lin (1988)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
10.1016/j.ijpharm.2012.12.013
Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems.
S. Bose (2013)
10.1016/S0031-6865(99)00003-5
Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers
M. Jumaa (1999)
Investigations on the transfer of lipophilic drug models from lipid nanoparticles to lipophilic acceptor compartments using different techniques
Mohamed rer. nat. Dawound (2011)
10.1111/j.2042-7158.1990.tb06609.x
Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions
F. Ishii (1990)
10.1016/0378-5173(89)90062-8
Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition
C. Washington (1989)
10.1016/S1773-2247(11)50006-1
Lecithin-based nanoemulsions
V. Klang (2011)
Transparent Dispersions of Milk Fat-Based Solid Lipid Nanoparticles for Delivery of beta-Carotene
Linhan Zhang (2013)
10.1081/DDC-120037608
In Vitro–In Vivo Characterization of Release Modifying Agents for Parenteral Sustained‐Release Ketorolac Formulation
V. Puri (2004)
10.1046/j.1365-2710.1997.93675936.x
Preparation and properties of a stable intravenous lorazepam emulsion
M. Ya-lin (1997)
See more
Semantic Scholar Logo Some data provided by SemanticScholar